Higher survival following transplantation with a mismatched unrelated donor with posttransplant cyclophosphamide‐based graft‐versus‐host disease prophylaxis than with double unit umbilical cord blood in patients with acute myeloid leukemia in first complete remission: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Frédéric Baron, Myriam Labopin, Jurjen Versluis, Jan Vydra, Peter A. von dem Borne, Emma Nicholson, Didier Blaise, Rachel Protheroe, Alexander Kulagin, Claude Eric Bulabois, Montserrat Rovira, Patrice Chevallier, Edouard Forcade, Jenny Byrne, Jaime Sanz, Annalisa Ruggeri, Mohamad Mohty, Fabio Ciceri

Open source

DOI
10.1002/ajh.27466
Published
2024-08-31
Container
American Journal of Hematology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ajh.27466,
  title = {Higher survival following transplantation with a mismatched unrelated donor with posttransplant cyclophosphamide‐based graft‐versus‐host disease prophylaxis than with double unit umbilical cord blood in patients with acute myeloid leukemia in first complete remission: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation},
  author = {Frédéric Baron and Myriam Labopin and Jurjen Versluis and Jan Vydra and Peter A. von dem Borne and Emma Nicholson and Didier Blaise and Rachel Protheroe and Alexander Kulagin and Claude Eric Bulabois and Montserrat Rovira and Patrice Chevallier and Edouard Forcade and Jenny Byrne and Jaime Sanz and Annalisa Ruggeri and Mohamad Mohty and Fabio Ciceri},
  year = {2024},
  journal = {American Journal of Hematology},
  doi = {10.1002/ajh.27466},
  url = {https://doi.org/10.1002/ajh.27466}
}

RIS

TY  - JOUR
TI  - Higher survival following transplantation with a mismatched unrelated donor with posttransplant cyclophosphamide‐based graft‐versus‐host disease prophylaxis than with double unit umbilical cord blood in patients with acute myeloid leukemia in first complete remission: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
AU  - Frédéric Baron
AU  - Myriam Labopin
AU  - Jurjen Versluis
AU  - Jan Vydra
AU  - Peter A. von dem Borne
AU  - Emma Nicholson
AU  - Didier Blaise
AU  - Rachel Protheroe
AU  - Alexander Kulagin
AU  - Claude Eric Bulabois
AU  - Montserrat Rovira
AU  - Patrice Chevallier
AU  - Edouard Forcade
AU  - Jenny Byrne
AU  - Jaime Sanz
AU  - Annalisa Ruggeri
AU  - Mohamad Mohty
AU  - Fabio Ciceri
PY  - 2024
JO  - American Journal of Hematology
DO  - 10.1002/ajh.27466
UR  - https://doi.org/10.1002/ajh.27466
ER  - 

APA

Baron, F., Labopin, M., Versluis, J., Vydra, J., Borne, P. A. V. D., Nicholson, E., Blaise, D., Protheroe, R., Kulagin, A., Bulabois, C. E., Rovira, M., Chevallier, P., Forcade, E., Byrne, J., Sanz, J., Ruggeri, A., Mohty, M., & Ciceri, F. (2024). Higher survival following transplantation with a mismatched unrelated donor with posttransplant cyclophosphamide‐based graft‐versus‐host disease prophylaxis than with double unit umbilical cord blood in patients with acute myeloid leukemia in first complete remission: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. American Journal of Hematology. https://doi.org/10.1002/ajh.27466

Source records